These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 29519889)

  • 1. Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.
    Liu C; Oikonomopoulos A; Sayed N; Wu JC
    Development; 2018 Mar; 145(5):. PubMed ID: 29519889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
    Qian L; Tcw J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Hybrid 2D-to-3D in vitro Differentiation Platform Improves Outcomes of Cerebral Cortical Organoid Generation in hiPSCs.
    Whye D; Norabuena EM; Srinivasan GR; Wood D; Polanco TJ; Makhortova NR; Sahin M; Buttermore ED
    Curr Protoc; 2024 Oct; 4(10):e70022. PubMed ID: 39400999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery.
    Costamagna G; Andreoli L; Corti S; Faravelli I
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Organoids: new perspectives and ethical issues].
    Chneiweiss H
    Med Sci (Paris); 2020 Feb; 36(2):99-100. PubMed ID: 32129740
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
    Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
    Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems.
    Silva-Pedrosa R; Salgado AJ; Ferreira PE
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures.
    Sacchetto C; Vitiello L; de Windt LJ; Rampazzo A; Calore M
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
    Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
    Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembly of differentiated progenitor cells facilitates spheroid human skin organoid formation and planar skin regeneration.
    Ebner-Peking P; Krisch L; Wolf M; Hochmann S; Hoog A; Vári B; Muigg K; Poupardin R; Scharler C; Schmidhuber S; Russe E; Stachelscheid H; Schneeberger A; Schallmoser K; Strunk D
    Theranostics; 2021; 11(17):8430-8447. PubMed ID: 34373751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
    Lee CT; Bendriem RM; Wu WW; Shen RF
    J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and Culture of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoid Cells.
    Yan Y; Arzua T; Logan S; Bai X
    Methods Mol Biol; 2022; 2454():483-494. PubMed ID: 33029748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of human airway-organoids from induced pluripotent stem cells (iPSCs).
    Wang R; McCauley KB; Kotton DN; Hawkins F
    Methods Cell Biol; 2020; 159():95-114. PubMed ID: 32586451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generating ventral spinal organoids from human induced pluripotent stem cells.
    Hor JH; Ng SY
    Methods Cell Biol; 2020; 159():257-277. PubMed ID: 32586446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically Amendable, Defined, and Rapid Induction of Human Brain Organoids from Induced Pluripotent Stem Cells.
    Tomaskovic-Crook E; Crook JM
    Methods Mol Biol; 2019; 1576():13-22. PubMed ID: 29119484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid.
    Nam KH; Yi SA; Jang HJ; Han JW; Lee J
    Arch Pharm Res; 2020 Sep; 43(9):877-889. PubMed ID: 32761309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex Organ Construction from Human Pluripotent Stem Cells for Biological Research and Disease Modeling with New Emerging Techniques.
    Matsumoto R; Yamamoto T; Takahashi Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identity and Maturity of iPSC-Derived Oligodendrocytes in 2D and Organoid Systems.
    Zeldich E; Rajkumar S
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.